Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine
· Delayed Price · Currency is JOD · Price in USD 3.650
-0.050 (-1.35%)
At close: Apr 17, 2025
PEX:BPC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 5.18 | 6.12 | 7.95 | 12.08 | 7.37 | Upgrade
|
| Depreciation & Amortization | 1.42 | 1.5 | 1.66 | 1.66 | 1.69 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | -0.05 | -0.05 | -0.16 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.69 | -0.27 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.63 | 1.24 | -0.88 | -2.03 | -0.99 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.85 | 0.21 | 0.17 | 0.27 | Upgrade
|
| Other Operating Activities | 0 | 1.73 | 1.08 | 2.21 | 1.57 | Upgrade
|
| Change in Accounts Receivable | -5.78 | -0.04 | -5.21 | -10.55 | 1.41 | Upgrade
|
| Change in Inventory | 1.3 | -0.93 | -0.55 | 0.54 | 0.23 | Upgrade
|
| Change in Other Net Operating Assets | 3.2 | 1.77 | 0.3 | -0.01 | -5.91 | Upgrade
|
| Operating Cash Flow | 6.96 | 12.16 | 5.21 | 3.65 | 5.63 | Upgrade
|
| Operating Cash Flow Growth | -42.79% | 133.66% | 42.70% | -35.22% | -49.09% | Upgrade
|
| Capital Expenditures | -1.52 | -3.33 | -3.59 | -0.93 | -0.5 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.05 | - | - | Upgrade
|
| Cash Acquisitions | -0.02 | -0.13 | - | -0.01 | -0.24 | Upgrade
|
| Divestitures | - | - | 0.01 | - | - | Upgrade
|
| Investment in Securities | -3.49 | -3.86 | 3.48 | -1.13 | -0.58 | Upgrade
|
| Investing Cash Flow | -5.04 | -7.01 | -0.05 | -1.11 | -2.95 | Upgrade
|
| Long-Term Debt Repaid | - | -1.22 | -0.82 | -1.17 | -1.17 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1.22 | -0.82 | -1.17 | -1.17 | Upgrade
|
| Issuance of Common Stock | 0 | 0 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -0.08 | -0.01 | -0 | Upgrade
|
| Common Dividends Paid | -1.94 | -3.88 | -1.94 | -2.85 | -4.18 | Upgrade
|
| Financing Cash Flow | -1.94 | -5.09 | -2.84 | -4.03 | -5.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | 0.05 | -0.45 | 0.07 | 0.2 | Upgrade
|
| Net Cash Flow | -0.04 | 0.11 | 1.86 | -1.42 | -2.47 | Upgrade
|
| Free Cash Flow | 5.43 | 8.83 | 1.62 | 2.72 | 5.13 | Upgrade
|
| Free Cash Flow Growth | -38.45% | 446.04% | -40.51% | -47.00% | -25.04% | Upgrade
|
| Free Cash Flow Margin | 13.37% | 20.47% | 3.44% | 5.98% | 14.30% | Upgrade
|
| Free Cash Flow Per Share | 0.15 | 0.23 | 0.04 | 0.07 | 0.13 | Upgrade
|
| Cash Income Tax Paid | 0.03 | 0.03 | 0.03 | - | 0 | Upgrade
|
| Levered Free Cash Flow | 4.76 | 5.21 | -0.98 | -1.17 | 5.59 | Upgrade
|
| Unlevered Free Cash Flow | 4.78 | 5.27 | -0.91 | -1.04 | 5.73 | Upgrade
|
| Change in Net Working Capital | -0.11 | -2.62 | 4.95 | 8.22 | -0.25 | Upgrade
|
Updated Feb 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.